1069 — China Health Technology Holding Share Price
0.000.00%
Last trade - 00:00- HK$50.70m
- HK$173.54m
- CNY58.72m
- 17
- 69
- 12
- 19
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.72 | ||
| Price to Tang. Book | 2.72 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.84 | ||
| EV to EBITDA | 0.67 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 154.55% | ||
| Return on Equity | n/a | ||
| Operating Margin | 358.32% | ||
Financial Summary
| Year End 30th Jun | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 51.36 | 54.25 | n/a | 6.76 | 58.72 | n/a | n/a | -7.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
China Health Technology Group Holding Co Ltd, formerly China Bozza Development Holdings Ltd, is a company principally engaged in the forestry management and ginseng business. The Company’s forestry management business is mainly engaged in the sales of timber logs harvested from forests. The Company’s ginseng business is mainly engaged in the planting and sales of compound hybridisation breed with traditional wild ginseng grown in the north or cold regions and other different varieties of ginseng. The Company mainly conducts businesses within the domestic market.
Directors
- Phillip Fei CHM (59)
- Wenjun Li CEO (60)
- Hing Hui EDR (46)
- Chi Yin Lai EDR (58)
- Yue Wang EDR (36)
- Sotong Gu NED (53)
- Lee Ni Wongi NED (54)
- Wenhong Huang NID (52)
- Zhaoxiang Liu NID (67)
- Guangmei Tian NID (54)
- Last Annual
- June 30th, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- June 10th, 2009
- Public Since
- October 8th, 2009
- No. of Employees
- 27
- Sector
- Food & Tobacco
- Industry
- Consumer Defensives
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 859,242,204
- Address
- Room 4009, 40F, Rongchao Trading Centr, SHENZHEN
- Web
- http://www.caflc.co/
- Phone
- +86 75582793080
- Auditors
- CCTH CPA Limited
Upcoming Events for 1069
Similar to 1069
Asian Citrus Holdings
Stock Exchange of Hong Kong Limited
Ausnutria Dairy
Stock Exchange of Hong Kong Limited
AustAsia
Stock Exchange of Hong Kong Limited
Besunyen Holdings Co
Stock Exchange of Hong Kong Limited
Chaoda Modern Agriculture (Holdings)
Stock Exchange of Hong Kong Limited
FAQ
What is the China Health Technology Holding share price?
As of Today at 20:00 UTC, shares in China Health Technology Holding are trading at HK$0.06. This share price information is delayed by 15 minutes.
How has the China Health Technology Holding share price performed this year?
Shares in China Health Technology Holding last closed at HK$0.06 and the price had moved by -41.58% over the past 365 days. In terms of relative price strength the China Health Technology Holding share price has underperformed the FTSE Developed Asia Pacific Index by -49.1% over the past year.
What are the analyst and broker recommendations for China Health Technology Holding?
There is no consensus recommendation for this security.
Find out moreWhat is the China Health Technology Holding dividend yield?
China Health Technology Holding does not currently pay a dividend.
Does China Health Technology Holding pay a dividend?
China Health Technology Holding does not currently pay a dividend.
When does China Health Technology Holding next pay dividends?
China Health Technology Holding does not currently pay a dividend.
How do I buy China Health Technology Holding shares?
To buy shares in China Health Technology Holding you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of China Health Technology Holding?
As of the previous close price of HK$0.06, shares in China Health Technology Holding had a market capitalisation of HK$50.70m.
Where are China Health Technology Holding shares listed?
Here are the trading details for China Health Technology Holding:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 1069
What kind of share is China Health Technology Holding?
Based on an overall assessment of its quality, value and momentum China Health Technology Holding is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a China Health Technology Holding share price forecast for 2024?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the China Health Technology Holding share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like China Health Technology Holding. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -0.26%.
As of the last closing price of HK$0.06, shares in China Health Technology Holding were trading +2.75% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the China Health Technology Holding PE Ratio?
The China Health Technology Holding PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.06.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of China Health Technology Holding?
China Health Technology Holding's management team is headed by:
- Phillip Fei - CHM
- Wenjun Li - CEO
- Hing Hui - EDR
- Chi Yin Lai - EDR
- Yue Wang - EDR
- Sotong Gu - NED
- Lee Ni Wongi - NED
- Wenhong Huang - NID
- Zhaoxiang Liu - NID
- Guangmei Tian - NID